(4,4-Dimethyl-pentylmercapto)-bernsteinsaeure | 100048-63-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (4,4-Dimethyl-pentylmercapto)-bernsteinsaeure
• 英文别名: 2-(4,4-Dimethylpentylsulfanyl)butanedioic acid；2-(4,4-dimethylpentylsulfanyl)butanedioic acid
• CAS: 100048-63-3
• 化学式: C₁₁H₂₀O₄S
• 分子量: 248.343
• InChiKey: JREDOQYKGZSQDQ-UHFFFAOYSA-N

物化性质

• 沸点：
  347.3±32.0 °C(Predicted)
• 密度：
  1.161±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  16
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  99.9
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  巯基丁二酸 、 4,4-二甲基-1-戊烯 在 过氧化苯甲酰 作用下， 以 甲醇 为溶剂， 生成 (4,4-Dimethyl-pentylmercapto)-bernsteinsaeure
  参考文献：
  名称：

  S-Alkylmercaptosuccinic Acids as Solid Derivatives of Olefins, Alkyl Bromides, and Mercaptans

  摘要：

  DOI：

  10.1021/jo01080a018

文献信息

• DYE COMPOUND, METHOD OF PRODUCING DIPYRROMETHENE METAL COMPLEX COMPOUND, METHOD OF PRODUCING DYE MULTIMER, SUBSTITUTED PYRROLE COMPOUND, COLORED CURABLE COMPOSITION, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR AND LIQUID CRYSTAL DISPLAY DEVICE
  申请人：FUJIFILM CORPORATION

  公开号：US20130137018A1

  公开（公告）日：2013-05-30

  The invention provides a dye compound having a partial structure represented by the following formula (5): wherein in formula (5), Dye represents a dye structure; G 1 represents NR or an oxygen atom; G 2 represents a monovalent substituent group having an −Es′ value as a steric parameter of 1.5 or more; p represents an integer from 1 to 8; when p is 2 or greater, the two or more structures represented by p may be the same or different from each other; and R represents a hydrogen atom or a monovalent substituent group.
• NEOSORAPHENS
  申请人：Helmoltz-Zentrum für Infektionsforschung GmbH

  公开号：US20170029436A1

  公开（公告）日：2017-02-02

  The present invention relates to compounds according to general formula (I); to compositions, including a pharmaceutical formulation and a combination preparation comprising one or more of the compound (s); to a process for their preparation; to uses thereof, including the use in the treatment or prevention of a viral infection or a Th17-associated inflammatory and/or autoimmune disease.
• US9116426B2
  申请人：——

  公开号：US9116426B2

  公开（公告）日：2015-08-25